IceCure Medical Stock Forecast

ICCM's stock price has decreased by -85.87% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, IceCure Medical stock has a consensus rating of "Strong Buy" and an average price target of $44.5. The average 1-year stock price forecast is 919.47% higher than the current stock price, while the lowest is $30 (+587.29%) and the highest is $73.5 (+1,583.85%).

Price Target: $44.5 (+919.47%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$44.5	$30	$73.5
Change	+587.29%	+919.47%	+587.29%	+1583.8%

Analyst Ratings

The average analyst rating for IceCure Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	1	1	1	1	1	2
Buy	2	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	2	2	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Buy Maintains $3 → $1	Buy	Maintains	$3 → $1	-77.09%	May 14, 2026
Scott Henry Alliance Global Partners	Alliance Global Partners	Buy Maintains $1	Buy	Maintains	$1	-77.09%	May 13, 2026

Financial Forecast

Revenue This Year

6.37M

from 3.38M

88.51%

from 3.38M

Revenue Next Year

12.55M

from 6.37M

96.95%

from 6.37M

EPS This Year

-0.17

from -0.24

EPS Next Year

-0.10

from -0.17

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.14M	3.09M	3.23M	3.29M	3.38M	6.37M
Revenue Growth	6.98%	-25.45%	4.67%	1.92%	2.67%	88.51%
Gross Profit	2.20M	1.45M	1.30M	1.45M	1.23M	2.86M
Gross Margin	53.04%	46.84%	40.26%	44.09%	36.28%	44.83%
Operating Income	-9.72M	-16.74M	-15.58M	-15.70M	-15.09M	-16.58M
Net Income	-9.90M	-16.98M	-14.65M	-15.32M	-15.06M	-16.32M
EPS	-	-	-	-	-0.24	-0.17
Free Cash Flow	-9.26M	-8.79M	-7.75M	-7.18M	-8.92M	-7.61M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	9.7M
Avg	6.4M
Low	4.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	186.5%
Avg	88.5%
Low	31.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.17
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-